{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:21:17Z","timestamp":1794939677422,"version":"4.9.1"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11S","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>To provide a comprehensive, evidence-based review of the complications associated with hyaluronic acid (HA) dermal fillers and to offer practical guidance for their identification, prevention, and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN<\/jats:title>\n                    <jats:p>Narrative review of the peer-reviewed literature, consensus guidelines, and postmarket surveillance data addressing the classification, pathophysiology, prevention, and treatment of HA filler complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FINDINGS<\/jats:title>\n                    <jats:p>Hyaluronic acid fillers carry a favorable safety profile, with severe complications reported in fewer than 0.01% of injection sites. Complications are classified by onset. Early-onset events include ecchymosis, injection-site and hypersensitivity reactions, product displacement, and vascular occlusion. Late-onset events include biofilm-associated infection, delayed inflammatory nodules, granulomas, and hyperpigmentation. Vascular occlusion is the most feared complication and may progress to skin necrosis, vision loss, or stroke; prompt recognition and high-dose hyaluronidase, increasingly aided by ultrasound guidance, are central to management. Prevention rests on sound anatomic knowledge, appropriate product selection, and careful injection technique, while treatment is tailored to the specific complication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY<\/jats:title>\n                    <jats:p>As filler use continues to expand, clinicians must be prepared to recognize, prevent, and manage the full spectrum of complications. This review consolidates current evidence into a practical framework intended to support safe practice and optimal patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000005380","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:09:47Z","timestamp":1791569387000},"page":"e122-e131","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["From Bruising to Blindness: A Practical Guide to Identifying and Managing Hyaluronic Acid Filler Complications"],"prefix":"10.1097","volume":"52","author":[{"given":"Payvand","family":"Kamrani","sequence":"first","affiliation":[{"name":"Aesthetic Solutions, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue Ellen","family":"Cox","sequence":"additional","affiliation":[{"name":"Aesthetic Solutions, Chapel Hill, North Carolina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Beleznay","sequence":"additional","affiliation":[{"name":"Humphrey and Beleznay Cosmetic Dermatology, Vancouver, British Columbia, Canada;"},{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Humphrey","sequence":"additional","affiliation":[{"name":"Humphrey and Beleznay Cosmetic Dermatology, Vancouver, British Columbia, Canada;"},{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"R1-20261117","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40257-015-0135-7","article-title":"Dermal fillers: an update","volume":"16","author":"Ballin","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"R3-20261117","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/SAP.0000000000004327","article-title":"Serious complications of hyaluronic acid fillers\u2014A retrospective study of 290,307 cases","volume":"94","author":"Tamura","year":"2025","journal-title":"Ann Plast Surg"},{"key":"R4-20261117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.joms.2019.08.003","article-title":"Complications and litigation associated with injectable facial fillers: a cross-sectional study","volume":"78","author":"Beauvais","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"key":"R5-20261117","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/DSS.0000000000002208","article-title":"Analysis of US Food and Drug Administration data on soft-tissue filler complications","volume":"46","author":"Ortiz","year":"2020","journal-title":"Dermatol Surg"},{"key":"R6-20261117","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/DSS.0000000000003350","article-title":"Postmarket safety surveillance of delayed complications for recent FDA-approved hyaluronic acid dermal fillers","volume":"48","author":"Cohen","year":"2022","journal-title":"Dermatol Surg"},{"key":"R7-20261117","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/PRS.0000000000002184","article-title":"Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers\u2014Evidence-and opinion-based review and consensus recommendations","volume":"137","author":"Signorini","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R8-20261117","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/odi.70109","article-title":"Adverse events in nonsurgical facial aesthetic procedures: a systematic review and meta\u2010analysis","volume":"32","author":"Cruz","year":"2026","journal-title":"Oral Dis"},{"key":"R9-20261117","doi-asserted-by":"crossref","first-page":"e12861","DOI":"10.1111\/dth.12861","article-title":"Treatment of injection\u2010induced ecchymoses with light\/laser\u2010assisted technology","volume":"32","author":"Verner","year":"2019","journal-title":"Dermatol Ther"},{"key":"R10-20261117","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/bjd.13362","article-title":"Perioperative management of and recommendations for antithrombotic medications in dermatological surgery","volume":"172","author":"Palamaras","year":"2015","journal-title":"Br J Dermatol"},{"key":"R11-20261117","first-page":"1138","article-title":"Purpura and fillers: a review of pre-procedural, intra-procedural, and post-procedural considerations","volume":"12","author":"Schlesinger","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"R12-20261117","first-page":"1097","article-title":"Myth versus reality: a review of social media claims and scientific evidence for Arnica montana in postinjectable procedures","volume":"10","author":"Ryzhaya","year":"2022","journal-title":"Dermatol Surg"},{"key":"R13-20261117","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/DSS.0000000000000701","article-title":"Is there a role for arnica and bromelain in prevention of post-procedure ecchymosis or edema? A systematic review of the literature","volume":"42","author":"Ho","year":"2016","journal-title":"Dermatol Surg"},{"key":"R14-20261117","doi-asserted-by":"crossref","first-page":"8159047","DOI":"10.1155\/2020\/8159047","article-title":"Safety assessment of high\u2010and low\u2010molecular\u2010weight hyaluronans (Profhilo) as derived from worldwide postmarketing data","volume":"2020","author":"Cassuto","year":"2020","journal-title":"Biomed Res Int"},{"key":"R15-20261117","first-page":"1184","article-title":"Post filler ecchymosis resolution with intense pulsed light","volume":"17","author":"Narurkar","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"R16-20261117","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/asj\/sjw251","article-title":"New high dose pulsed hyaluronidase protocol for hyaluronic acid filler vascular adverse events","volume":"37","author":"DeLorenzi","year":"2017","journal-title":"Aesthet Surg J"},{"key":"R17-20261117","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2017.01.035","article-title":"Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique","volume":"77","author":"Silpa-Archa","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"R18-20261117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lsm.23850","article-title":"Expert consensus on clinical recommendations for fractional ablative CO2 laser, in facial skin rejuvenation treatment","volume":"57","author":"Levy","year":"2025","journal-title":"Lasers Surg Med"},{"key":"R19-20261117","doi-asserted-by":"crossref","first-page":"e2061","DOI":"10.1097\/GOX.0000000000002061","article-title":"Complication management following rejuvenation procedures with hyaluronic acid fillers\u2014an algorithm-based approach","volume":"6","author":"Snozzi","year":"2018","journal-title":"Plast Reconstr Surgery\u2013Global Open"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.clindermatol.2024.05.006","article-title":"Ultrasonographic features of nonvascular complications of hyaluronic acid fillers: a retrospective study at a reference center for dermatologic ultrasonography","volume":"42","author":"Gonzalez","year":"2024","journal-title":"Clin Dermatol"},{"key":"R21-20261117","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0036-1592340","article-title":"Adverse reactions to injectable fillers","volume":"32","author":"Fitzgerald","year":"2016","journal-title":"Facial Plast Surg"},{"key":"R22-20261117","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/DSS.0000000000002911","article-title":"A systematic review supporting the American Society for Dermatologic Surgery Guidelines on the prevention and treatment of adverse events of injectable fillers","volume":"47","author":"Nayfeh","year":"2021","journal-title":"Dermatol Surg"},{"key":"R23-20261117","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.joms.2016.09.004","article-title":"An overview of infections associated with soft tissue facial fillers: identification, prevention, and treatment","volume":"75","author":"Ferneini","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"R24-20261117","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/2049-632X.12139","article-title":"Bacterial biofilm formation and treatment in soft tissue fillers","volume":"70","author":"Alhede","year":"2014","journal-title":"Pathog Dis"},{"key":"R25-20261117","doi-asserted-by":"crossref","first-page":"1297948","DOI":"10.3389\/fmicb.2023.1297948","article-title":"Biofilm formation is a risk factor for late and delayed complications of filler injection","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"key":"R26-20261117","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/PRS.0000000000003067","article-title":"The role of bacterial biofilm in adverse soft-tissue filler reactions: a combined laboratory and clinical study","volume":"139","author":"Saththianathan","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R27-20261117","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1090820X12471944","article-title":"Mycobacterium chelonae facial infections following injection of dermal filler","volume":"33","author":"Rodriguez","year":"2013","journal-title":"Aesthet Surg J"},{"key":"R28-20261117","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bjps.2024.02.010","article-title":"A treatment algorithm for hyaluronic acid filler related complications of the face","volume":"91","author":"Zaccaria","year":"2024","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R29-20261117","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/ph18060800","article-title":"Fluoroquinolones for dermatologists: a practical guide to clinical use and risk management","volume":"18","author":"Wahood","year":"2025","journal-title":"Pharmaceuticals"},{"key":"R30-20261117","doi-asserted-by":"crossref","first-page":"107259","DOI":"10.1016\/j.ijid.2024.107259","article-title":"Demographic and clinical features of nontuberculous mycobacteria infection resulting from cosmetic procedures: a systematic review","volume":"149","author":"Ma","year":"2024","journal-title":"Int J Infect Dis"},{"key":"R31-20261117","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.bjps.2020.08.012","article-title":"Granulomas and nongranulomatous nodules after filler injection: different complications require different treatments","volume":"73","author":"Modarressi","year":"2020","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R32-20261117","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/odi.15143","article-title":"Oral\/perioral reactions to injectable soft tissue fillers: a clinicopathological multicentric study","volume":"31","author":"Pires","year":"2025","journal-title":"Oral Dis"},{"key":"R33-20261117","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/IOP.0000000000000368","article-title":"Filler migration: a number of mechanisms to consider","volume":"31","author":"Jordan","year":"2015","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R34-20261117","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/DSS.0000000000004257","article-title":"Post-treatment displacement of facial soft tissue fillers\u2014a retrospective ultrasound-based investigation of 382 zygomatic regions","volume":"50","author":"Schelke","year":"2024","journal-title":"Dermatol Surg"},{"key":"R35-20261117","doi-asserted-by":"crossref","first-page":"NP559","DOI":"10.1093\/asj\/sjaa264","article-title":"Filler migration to the orbit","volume":"41","author":"Hamed-Azzam","year":"2021","journal-title":"Aesthet Surg J"},{"key":"R36-20261117","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1097\/PRS.0b013e31829e52a7","article-title":"A problem-oriented approach to nodular complications from hyaluronic acid and calcium hydroxylapatite fillers: classification and recommendations for treatment","volume":"132","author":"Cassuto","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"R37-20261117","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/01.DSS.0000452646.76270.53","article-title":"Relationship between delayed reactions to dermal fillers and biofilms: facts and considerations","volume":"40","author":"Beer","year":"2014","journal-title":"Dermatol Surg"},{"key":"R38-20261117","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/DSS.0000000000000418","article-title":"Delayed-onset nodules secondary to a smooth cohesive 20 mg\/mL hyaluronic acid filler: cause and management","volume":"41","author":"Beleznay","year":"2015","journal-title":"Dermatol Surg"},{"key":"R39-20261117","doi-asserted-by":"crossref","first-page":"NP438","DOI":"10.1093\/asj\/sjad028","article-title":"Making sense of late tissue nodules associated with hyaluronic acid injections","volume":"43","author":"Goodman","year":"2023","journal-title":"Aesthet Surg J"},{"key":"R40-20261117","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaad.2020.01.066","article-title":"Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20-mg\/mL hyaluronic acid filler in 4500 patients","volume":"83","author":"Humphrey","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R41-20261117","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/DSS.0000000000002921","article-title":"Preventing and treating adverse events of injectable fillers: evidence-based recommendations from the American Society for Dermatologic Surgery Multidisciplinary Task Force","volume":"47","author":"Jones","year":"2021","journal-title":"Dermatol Surg"},{"key":"R42-20261117","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/DSS.0000000000001814","article-title":"Delayed-onset nodules to differentially crosslinked hyaluronic acids: comparative incidence and risk assessment","volume":"45","author":"Sadeghpour","year":"2019","journal-title":"Dermatol Surg"},{"key":"R43-20261117","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1097\/PRS.0b013e3181858f4f","article-title":"Foreign body granulomas after all injectable dermal fillers: part 2. Treatment options","volume":"123","author":"Lemperle","year":"2009","journal-title":"Plast Reconstr Surg"},{"key":"R44-20261117","doi-asserted-by":"crossref","first-page":"e825","DOI":"10.1097\/SCS.0000000000011744","article-title":"Minimally invasive treatment for facial injection infection","volume":"36","author":"Jiang","year":"2025","journal-title":"J Craniofac Surg"},{"key":"R45-20261117","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.3390\/jcm14197078","article-title":"Colchicine in contemporary pharmacotherapy: mechanistic insights and clinical Horizons","volume":"14","author":"Wo\u0142owiec","year":"2025","journal-title":"J Clin Med"},{"issue":"(Suppl 2)","key":"R46-20261117","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1524-4725.2009.01347.x","article-title":"Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients","volume":"35","author":"Wiest","year":"2009","journal-title":"Dermatol Surg"},{"key":"R47-20261117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-021-02190-6","article-title":"COVID-19\/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment","volume":"314","author":"Munavalli","year":"2022","journal-title":"Arch Dermatol Res"},{"key":"R48-20261117","doi-asserted-by":"crossref","first-page":"1698816","DOI":"10.3389\/fimmu.2025.1698816","article-title":"Clinical updates of JAK inhibitors in cutaneous granulomatous diseases","volume":"16","author":"Gu","year":"2025","journal-title":"Front Immunol"},{"key":"R49-20261117","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.36849\/JDD.7271","article-title":"Post-hyaluronic acid filler reaction treated with abrocitinib: a case report","volume":"23","author":"Lopez","year":"2024","journal-title":"J Drugs Dermatol"},{"key":"R50-20261117","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/SCS.0000000000011175","article-title":"Understanding vascular complications arising from dermal filler injection","volume":"36","author":"Yi","year":"2025","journal-title":"J Craniofac Surg"},{"key":"R51-20261117","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/jcm14030802","article-title":"Critical ischemia following hyaluronic acid filler injection: a case report","volume":"14","author":"Turcza","year":"2025","journal-title":"J Clin Med"},{"key":"R52-20261117","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1007\/s00266-025-05104-3","article-title":"Guide for managing vascular occlusion caused by fillers with exclusive cutaneous involvement: a review of diagnosis, classification, and treatment","volume":"50","author":"Madero-P\u00e9rez","year":"2026","journal-title":"Aesthet Plast Surg"},{"key":"R53-20261117","first-page":"1097","article-title":"Reviewing the role of angiosomes in filler-induced tissue necrosis: observed patterns and clinical signs","volume":"10","author":"Myers","year":"2022","journal-title":"Dermatol Surg"},{"key":"R54-20261117","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jocd.14032","article-title":"Ultrasound patterns of different dermal filler materials used in aesthetics","volume":"20","author":"Urdiales\u2010G\u00e1lvez","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R55-20261117","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaad.2019.07.032","article-title":"Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers","volume":"88","author":"Schelke","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"R56-20261117","first-page":"E69","article-title":"Guideline for the safe use of hyaluronidase in aesthetic medicine, including modified high-dose protocol","volume":"14","author":"Murray","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"key":"R57-20261117","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5301\/jva.5000233","article-title":"Anesthesia for vascular access surgery","volume":"15","author":"Shemesh","year":"2014","journal-title":"J Vasc Access"},{"key":"R58-20261117","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/IOP.0000000000000446","article-title":"Rethinking the role of nitroglycerin ointment in ischemic vascular filler complications: an animal model with ICG imaging","volume":"32","author":"Hwang","year":"2016","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R59-20261117","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/asj\/sjag002","article-title":"Consensus guidelines for the management of tissue filler-induced vision loss in the United Kingdom","volume":"46","author":"Sansome","year":"2026","journal-title":"Aesthet Surg J"},{"key":"R60-20261117","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/asj\/sjz312","article-title":"A consensus on minimizing the risk of hyaluronic acid embolic visual loss and suggestions for immediate bedside management","volume":"40","author":"Goodman","year":"2020","journal-title":"Aesthet Surg J"},{"key":"R61-20261117","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ophtha.2025.01.020","article-title":"Vision-threatening complications of soft tissue fillers: a report by the American Academy of Ophthalmology","volume":"132","author":"Foster","year":"2025","journal-title":"Ophthalmology"},{"key":"R62-20261117","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/asj\/sjae091","article-title":"Update on blindness from filler: review of prognostic factors, management approaches, and a century of published cases","volume":"44","author":"Doyon","year":"2024","journal-title":"Aesthet Surg J"},{"key":"R63-20261117","doi-asserted-by":"crossref","first-page":"e70336","DOI":"10.1111\/jocd.70336","article-title":"EYE\u2010CODE protocol for the nonophthalmologist for treatment of retinal artery occlusion after intra\u2010arterial injection of soft\u2010tissue fillers: 2025 update","volume":"24","author":"Barbarino","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"R64-20261117","doi-asserted-by":"crossref","first-page":"2443111","DOI":"10.1080\/09546634.2024.2443111","article-title":"Cosmetic filler-induced hair loss: case series and literature review","volume":"36","author":"Xie","year":"2024","journal-title":"J Dermatol Treat"},{"key":"R65-20261117","doi-asserted-by":"crossref","first-page":"e16684","DOI":"10.1111\/jocd.16684","article-title":"Dermal filler\u2010induced alopecia: a case report and literature review","volume":"24","author":"Albargawi","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"R66-20261117","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamadermatol.2020.5102","article-title":"Rates of vascular occlusion associated with using needles vs cannulas for filler injection","volume":"157","author":"Alam","year":"2021","journal-title":"JAMA Dermatol"},{"key":"R67-20261117","doi-asserted-by":"crossref","first-page":"504e","DOI":"10.1097\/PRS.0000000000005321","article-title":"Arterial wall forces in needles versus cannulas","volume":"143","author":"Pavicic","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R68-20261117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40001-016-0201-5","article-title":"Hyaluronidase: from clinical applications to molecular and cellular mechanisms","volume":"21","author":"Buhren","year":"2016","journal-title":"Eur J Med Res"},{"key":"R69-20261117","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/asj\/sjaf127","article-title":"Comparison of the degradability of hyaluronic acid by ovine and recombinant human hyaluronidase","volume":"45","author":"Safran","year":"2025","journal-title":"Aesthet Surg J"},{"key":"R70-20261117","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.bjps.2021.03.125","article-title":"Use of hyaluronidase in plastic surgery: a review","volume":"74","author":"Sharma","year":"2021","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R71-20261117","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00266-023-03348-5","article-title":"Allergic complications of hyaluronidase injection: risk factors, treatment strategies, and recommendations for management","volume":"48","author":"Guliyeva","year":"2024","journal-title":"Aesthet Plast Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DSS.0000000000005380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:00:50Z","timestamp":1794938450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DSS.0000000000005380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":70,"journal-issue":{"issue":"11S","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000005380","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]}}}